14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis.

M. Ozawa, P. I. Terasaki, R. Castro, J. Alberu, L. Morales-Buenrostro, I. Alvarez, R. Toledo, H. Alvez, M. Monteiro, J. Teixeira, P. Campbell, M. Ciszek, D. Charron, C. Gautreau, F. Christiansen, L. Langan, R. Conca, H. Grosse-Wilde, F. Heinemann, M. KamounT. Kobayashi, P. Kupatawintu, W. LeFor, N. Mehra, A. Panigrahi, D. Norman, A. Piazza, F. Poli, R. Roy, C. Schonemann, N. Lachmann, G. Sireci, K. Tanabe, H. Ishida, E. Van den Berg-Loonen, A. Zeevi

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

The three-year follow-up of 4,144 patients of the 14th International Workshop Prospective Chronic Rejection study has reinforced the evidence that post-transplant HLA antibodies are predictive of long-term graft loss. Three years after a single testing for HLA antibodies, 10% of kidney recipients who were antibody-positive had lost their grafts, in contrast to only 5% of antibody-negative patients (p<0.0001). The adverse effect of post-transplant antibodies on graft survival was also observed in lung, heart, and liver transplants. Donor-specific antibodies and 'strong' non-DSA had stronger association with graft loss than 'moderate' non-DSA. Periodic antibody monitoring, combined with specificity and strength analysis, would help in the early identification of allograft recipients who are at high risk of graft failure.

Original languageEnglish (US)
Pages (from-to)255-260
Number of pages6
JournalClinical transplants
StatePublished - 2007

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ozawa, M., Terasaki, P. I., Castro, R., Alberu, J., Morales-Buenrostro, L., Alvarez, I., Toledo, R., Alvez, H., Monteiro, M., Teixeira, J., Campbell, P., Ciszek, M., Charron, D., Gautreau, C., Christiansen, F., Langan, L., Conca, R., Grosse-Wilde, H., Heinemann, F., ... Zeevi, A. (2007). 14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis. Clinical transplants, 255-260.